These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35841463)

  • 21. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
    PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.
    Pyra M; Brewer R; Rusie L; Kline J; Willis I; Schneider J
    J Acquir Immune Defic Syndr; 2022 Feb; 89(2):166-171. PubMed ID: 34636809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women.
    Hurwitz KE; Isehunwa OO; Hendrickson KR; Jaggernath M; Kriel Y; Smith PM; Mathenjwa M; Bennett K; Psaros C; Baeten JM; Bangsberg DR; Haberer JE; Smit JA; Matthews LT
    Front Reprod Health; 2023; 5():1263422. PubMed ID: 37860779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
    Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
    J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral PrEP Consultations Among Adolescent Girls and Young Women in Kisumu County, Kenya: Insights from the DREAMS Program.
    Heck CJ; Mathur S; Alwang'a H; Daniel OM; Obanda R; Owiti M; Okal J
    AIDS Behav; 2022 Aug; 26(8):2516-2530. PubMed ID: 35099640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.
    Pyra M; Haberer JE; Heffron R; Kidoguchi L; Brown ER; Bukusi EA; Asiimwe S; Celum C; Katabira E; Mugo NR; Baeten JM;
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):41-45. PubMed ID: 29016523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoption of HIV pre-exposure prophylaxis among women at high risk of HIV infection in Kenya.
    Bien-Gund CH; Ochwal P; Marcus N; Bair EF; Napierala S; Maman S; Agot K; Thirumurthy H
    PLoS One; 2022; 17(9):e0273409. PubMed ID: 36084050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya.
    Bazzi AR; Yotebieng K; Otticha S; Rota G; Agot K; Ohaga S; Syvertsen JL
    J Int AIDS Soc; 2019 Apr; 22(4):e25266. PubMed ID: 30983147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa.
    Velloza J; Baeten JM; Haberer J; Ngure K; Irungu E; Mugo NR; Celum C; Heffron R;
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):330-338. PubMed ID: 30063651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
    Velloza J; Donnell D; Hosek S; Anderson PL; Chirenje ZM; Mgodi N; Bekker LG; Marzinke MA; Delany-Moretlwe S; Celum C
    Lancet HIV; 2022 Oct; 9(10):e680-e689. PubMed ID: 36087612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivering PrEP to Young Women in a Low-Income Setting in South Africa: Lessons for Providing Both Convenience and Support.
    Cassidy T; Ntuli N; Kilani C; Malabi N; Rorwana B; Mutseyekwa T; O'Connell R; Steele SJ; Ndlovu Z; Ellman T; de Azevedo V; Pfaff C; Nelson A; Duran LT
    AIDS Behav; 2022 Jan; 26(1):147-159. PubMed ID: 34259963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya.
    Wanga V; Omollo V; Bukusi EA; Odoyo JB; Morton JF; Kidoguchi L; Johnson R; Hughes JP; Celum C; Baeten JM
    J Int AIDS Soc; 2020 Aug; 23(8):e25561. PubMed ID: 32820597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study.
    Monteiro Spindola Marins L; Silva Torres T; Luz PM; Moreira RI; Leite IC; Hoagland B; Kallas EG; Madruga JV; Grinsztejn B; Veloso VG;
    Int J STD AIDS; 2021 Nov; 32(13):1231-1241. PubMed ID: 34311605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT.
    Velloza J; Heffron R; Amico KR; Rowhani-Rahbar A; Hughes JP; Li M; Dye BJ; Celum C; Bekker LG; Grant RM;
    AIDS Behav; 2020 Jul; 24(7):2178-2187. PubMed ID: 31955360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
    Haberer JE; Baeten JM; Campbell J; Wangisi J; Katabira E; Ronald A; Tumwesigye E; Psaros C; Safren SA; Ware NC; Thomas KK; Donnell D; Krows M; Kidoguchi L; Celum C; Bangsberg DR
    PLoS Med; 2013; 10(9):e1001511. PubMed ID: 24058300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-reported and pill count measures of adherence to oral HIV PrEP among female sex workers living in South-Western Uganda.
    Nakiganda LJ; Grulich AE; Poynten IM; Serwadda D; Bazaale JM; Jin J; Bavinton BR
    PLoS One; 2022; 17(11):e0277226. PubMed ID: 36355810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point-of-Care Test for Assessing Tenofovir Adherence: Feasibility and Recommendations from Women in an Oral PrEP Program in Kenya and Their Healthcare Providers.
    Thuo N; Polay M; Leddy AM; Ngure K; Chatterhee P; Gandhi M; Amico KR
    AIDS Behav; 2021 Nov; 25(11):3617-3629. PubMed ID: 33893877
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Vera M; Bukusi E; Achieng P; Aketch H; Araka E; Baeten JM; Beima-Sofie K; John-Stewart G; Kohler PK; Mugambi ML; Nyerere B; Odoyo J; Omom C; Omondi C; Ortblad KF; Pintye J
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231215882. PubMed ID: 37997351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.